Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,630 active trials11 approved drugs139 evidence items
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,171 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04792749 | Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer | unknown | Phase 3 | 77 | Samsung Medical CenterOTHER | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05695690 | Role of US in Uterine Fibroids in Comparison With MRI Using FIGO Classification | unknown | — | 43 | Assiut UniversityOTHER | 0 | Apr 11, 2023 | clinicaltrials |
| NCT05807672 |
| Magnetic Resonance Fingerprinting in the Imaging of Endometrial Cancer(MARF-E) |
| unknown |
| — |
| 150 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER |
| 1 |
| Apr 11, 2023 |
| clinicaltrials |
| NCT05806125 | Clinical Value of the Fertility-preserving Surgery in Cervical Cancer | unknown | — | 100 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Apr 10, 2023 | clinicaltrials |
| NCT05393440 | First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer(CC-OV01) | unknown | Phase 1 | 18 | Zhongnan HospitalOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT05801263 | ctDNA Methylation for Epithelial Ovarian Cancer | unknown | — | 5,000 | Lei LiOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801276 | ctDNA Methylation for Detecting Ovarian Cancer | unknown | — | 1,400 | Lei LiOTHER | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801783 | A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Ovarian Cancer | unknown | Early Phase 1 | 10 | Shanghai Yunying Medical TechnologyINDUSTRY | 1 | Apr 6, 2023 | clinicaltrials |
| NCT05801796 | Appraising Medical Trial Experiences of Ovarian Cancer Patients | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Apr 6, 2023 | clinicaltrials |
| NCT05792254 | Huaier Granule in Patients With Stage I Primary Ovarian Fallopian Tube Cancer After Peritoneal Cancer | unknown | N/A | 30 | Ruijin HospitalOTHER | 0 | Mar 31, 2023 | clinicaltrials |
| NCT05793749 | Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy | unknown | N/A | 400 | Chongqing University Cancer HospitalOTHER | 1 | Mar 31, 2023 | clinicaltrials |
| NCT00492778 | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer | unknown | Phase 2 | 165 | GOG FoundationNETWORK | 2 | Mar 29, 2023 | clinicaltrials |
| NCT03695809 | The Association of G9a Protein and Clinical Outcome of Patients With Vulvar Cancer | unknown | — | 30 | Far Eastern Memorial HospitalOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT05789628 | Discovering Factors in Cervical Cancer Patients' Clinical Trial Experiences | unknown | — | 500 | Power Life Sciences Inc.INDUSTRY | 0 | Mar 29, 2023 | clinicaltrials |
| NCT04369352 | Register to Describe the Treatment Pattern of Platinum-sensitive Relapsed Epithelial Ovarian Cancer Patients in Austria | unknown | — | 150 | Medical University InnsbruckOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05776355 | NKG2D CAR-NK & Ovarian Cancer | unknown | N/A | 18 | Hangzhou Cheetah Cell Therapeutics Co., LtdOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT00326456 | MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer | unknown | Phase 3 | 820 | National Cancer Institute, NaplesOTHER | 3 | Mar 27, 2023 | clinicaltrials |
| NCT02599116 | Gastrointestinal Microbiome Study of Appendiceal Cancer | unknown | N/A | 24 | Mercy Medical CenterOTHER | 1 | Mar 27, 2023 | clinicaltrials |
| NCT00660842 | Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer(MITO-7) | unknown | Phase 3 | 800 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01061619 | Pathway to Diagnosis of Ovarian Cancer(MITO-12) | unknown | — | 400 | National Cancer Institute, NaplesOTHER | 3 | Mar 24, 2023 | clinicaltrials |
| NCT01706120 | Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab(MITO16/MANGO-2) | unknown | Phase 4 | 400 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT01802749 | Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer(MITO16MANGO2b) | unknown | Phase 3 | 406 | National Cancer Institute, NaplesOTHER | 5 | Mar 24, 2023 | clinicaltrials |
| NCT03410784 | Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer(MITO28MaNGOov4) | unknown | Phase 2 | 72 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT03561207 | 3D Prediction of Patient-Specific Response(3D-PREDICT) | unknown | — | 570 | KIYATECINDUSTRY | 1 | Mar 24, 2023 | clinicaltrials |
| NCT04091204 | Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study(MITO 31) | unknown | Phase 2 | 200 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05233982 | MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer(MITO 35a) | unknown | Phase 2 | 200 | National Cancer Institute, NaplesOTHER | 1 | Mar 24, 2023 | clinicaltrials |
| NCT05783986 | Developing a MRI-based Deep Learning Model to Predict MMR Status | unknown | — | 600 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Mar 24, 2023 | clinicaltrials |
| NCT05620355 | Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids. | unknown | Phase 3 | 312 | Bio Genuine (Shanghai) Biotech Co., Ltd.INDUSTRY | 1 | Mar 21, 2023 | clinicaltrials |
| NCT05633342 | Project CADENCE (CAncer Detected Early caN be CurEd)(CADENCE) | unknown | — | 15,000 | MiRXES Pte LtdINDUSTRY | 1 | Mar 20, 2023 | clinicaltrials |
| NCT05769205 | MRI in Ovarian Tumors | unknown | N/A | 25 | Assiut UniversityOTHER | 0 | Mar 15, 2023 | clinicaltrials |
| NCT01881659 | Cervical Cancer Screening With Human Papillomavirus Testing(ESTAMPA) | unknown | — | 50,000 | International Agency for Research on CancerOTHER | 9 | Mar 14, 2023 | clinicaltrials |
| NCT04724031 | Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer | unknown | — | 150 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05755893 | Unusual Infiltrative Patterns of Malignant Cells in Endometrial Carcinoma and Immunohistochemical Expression of P53 | unknown | — | 100 | Assiut UniversityOTHER | 0 | Mar 14, 2023 | clinicaltrials |
| NCT05761132 | Neo-adjuvant Pembrolizumab in Vulvar Squamous Cell Carcinoma: a Clinical Proof-of-concept Study(Apollo) | unknown | Phase 2 | 40 | Leiden University Medical CenterOTHER | 0 | Mar 9, 2023 | clinicaltrials |
| NCT05184140 | Mapping Sentinel Lymph Node in Initial Stages of Ovarian Cancer(MELISA) | unknown | N/A | 62 | Hospital Clinic of BarcelonaOTHER | 1 | Mar 7, 2023 | clinicaltrials |
| NCT04752865 | Effects of Cytotoxic Chemotherapy and PARP Inhibition on the Genomic Contexture of Ovarian Cancer | unknown | — | 50 | Hellenic Cooperative Oncology GroupOTHER | 1 | Mar 1, 2023 | clinicaltrials |
| NCT05733793 | Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.(GYNGER) | unknown | — | 300 | National Cancer Institute, NaplesOTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05741671 | Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management(MYOVASC) | unknown | — | 760 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 23, 2023 | clinicaltrials |
| NCT05265117 | The Efficacy of Hyperthermic Intraperitoneal Chemotherapy to Ovarian Cancer Patients With Homologous Recombination Repair Defect and Residual: a Prospective Cohort Study | unknown | — | 310 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 17, 2023 | clinicaltrials |
| NCT04438564 | Immunoassay and Regulation of Traditional Chinese Medicine on Cancer Patients | unknown | N/A | 300 | China Medical University HospitalOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05193669 | Clinical Validation of Molecular Triage in HR-HPV Positive Women(VALTRIHP) | unknown | — | 23,941 | Hiantis SrlINDUSTRY | 1 | Feb 8, 2023 | clinicaltrials |
| NCT05717634 | Endometrial Changes in Breast Cancer Women. | unknown | — | 829 | Regina Elena Cancer InstituteOTHER | 1 | Feb 8, 2023 | clinicaltrials |
| NCT03321188 | Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients | unknown | Phase 2 | 20 | Andrea JewellOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT04689178 | Cervical Cancer Screening Uptake: A Randomised Controlled Trial Assessing the Effect of Sending Invitation Letters to Nonadherent Women(IMPACTGP) | unknown | N/A | 195,000 | Nantes University HospitalOTHER | 1 | Feb 6, 2023 | clinicaltrials |
| NCT05287048 | Evaluation of MCM5 in Postmenopausal Bleeding Patients | unknown | — | 2,000 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05453825 | A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors | unknown | Phase 2 | 180 | OncXerna Theraputics, Inc.INDUSTRY | 1 | Jan 31, 2023 | clinicaltrials |
| NCT05707312 | Staging Endometrial caNcer Based on molEcular ClAssification | unknown | — | 1,032 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jan 31, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Apr 13, 2023source: clinicaltrials